{"id":"NCT00794157","sponsor":"Novartis Pharmaceuticals","briefTitle":"Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A 12-week Treatment, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (150 and 300 µg Once Daily [od]) in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2008-11-19","resultsPosted":"2011-08-17","lastUpdate":"2011-08-17"},"enrollment":347,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Indacaterol 150 μg capsules","otherNames":[]},{"type":"DRUG","name":"Indacaterol 300 μg capsules","otherNames":[]},{"type":"DRUG","name":"Placebo capsules","otherNames":[]}],"arms":[{"label":"Indacaterol 150 µg","type":"EXPERIMENTAL"},{"label":"Indacaterol 300 µg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study was designed to provide pivotal confirmation of efficacy and safety data for 2 doses of indacaterol (150 and 300 µg once daily \\[od\\]) in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Data from this study will be used for the registration of indacaterol in Japan.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of Treatment (Week 12 + 1 Day, Day 85)","timeFrame":"End of treatment (Week 12 + 1 day, Day 85)","effectByArm":[{"arm":"Indacaterol 150 μg","deltaMin":1.34,"sd":0.024},{"arm":"Indacaterol 300 μg","deltaMin":1.37,"sd":0.023},{"arm":"Placebo","deltaMin":1.17,"sd":0.025}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":11},"locations":{"siteCount":60,"countries":["Hong Kong","India","Japan","Singapore","South Korea","Taiwan"]},"refs":{"pmids":["23040786"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":114},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Cough"]}}